CRMB and HIMSB Explained: Binance's Tokenized Salesforce (2026)

What are CRMB and HIMSB? Simply put, they are two tokenized securities within Binance's bStocks ecosystem: CRMB provides economic exposure to Salesforce (NYSE: CRM), and HIMSB provides economic exposure to Hims & Hers Health (NYSE: HIMS). Both exist as tokens on BNB Smart Chain and can be traded with USDT in crypto accounts—but they are not cryptocurrencies issued by Salesforce or Hims, nor do they equate to directly holding company shares in a traditional securities account.

According to Binance's announcement, CRMB/USDT and HIMSB/USDT spot trading opened on September 9, 2026, at 12:00 UTC (20:00 Beijing time); withdrawals opened at 13:00 UTC the same day. Both assets follow the same bStocks issuance framework, yet the underlying companies have fundamentally different investment theses: CRMB hinges on whether Salesforce can re-accelerate growth through Agentforce, Data 360, and enterprise AI; HIMSB hinges on whether Hims can restore gross margins and manage GLP-1, compliance, and customer acquisition risks while sustaining rapid revenue and user growth. Binance listing announcement

Risk Disclaimer: This material is current as of September 9, 2026, and is intended solely for product mechanism explanation and investment research. It does not constitute investment advice, performance guarantees, or trading recommendations. Tokenized securities carry both underlying stock risks and tokenization risks, and are subject to regional eligibility restrictions. Before placing orders, verify local laws, product documentation, contract addresses, underlying share prices, proof of collateral, and real-time premiums/discounts.

Key Takeaways: 7 Things to Know Before Investing in CRMB and HIMSB

1. CRMB corresponds to Salesforce stock (CRM), and HIMSB corresponds to Hims & Hers Health stock (HIMS).
2. Both are bStocks tokenized security certificates—not meme coins, platform governance tokens, or official tokens issued by the listed companies.
3. bStocks are issued by BTech Holdings Limited, a special purpose vehicle registered in the Abu Dhabi Global Market (ADGM). Binance primarily provides trading, conversion, and related service access.
4. The product structure aims to back each bStock with the corresponding underlying securities or other eligible assets, but holding a bStock does not make you a direct shareholder of the underlying company.
5. Binance Spot supports 24/7 bStocks trading, so CRMB vs. CRM and HIMSB vs. HIMS may experience short-term premiums or discounts.
6. Cash dividends, stock splits, and reverse splits are primarily reflected through the Multiplier mechanism; on-chain raw balances may differ from the effective balance shown in the interface.
7. CRMB follows a mature enterprise software and AI commercialization logic; HIMSB follows a high-growth healthcare platform, weight-loss business, and regulatory risk profile. They cannot be managed with the same position-sizing or valuation approach.

1. What Are CRMB and HIMSB? Confirm the Underlying Stocks, Network, and Contracts

CRMB's underlying reference asset is Salesforce common stock (ticker: CRM); HIMSB's underlying reference is Hims & Hers Health common stock (ticker: HIMS). Both are bStocks issued by BTech Holdings Limited and circulate on BNB Smart Chain.

As of September 9, 2026, public block explorers and market pages identify the contracts as:

• CRMB: 0x8c433eca1be0e2a357015602f63751c768f6f643
• HIMSB: 0xee6f4bcc88c2c8583d5a65c7d0c877b464100711

Contracts must be verified character by character. There are similar assets in the market, such as CRMOn and HIMSon issued by Ondo, or HIMSx from the xStocks system. They may track the same companies but have different issuers, legal documentation, networks, redemption terms, and contracts. Do not assume they are interchangeable or can be deposited to the same address just because the ticker matches.

CRMB and HIMSB are correctly classified as "Tokenized Securities," not ordinary "new coins." To understand them, first study the issuance structure, second study the underlying companies, and only third observe crypto market prices and liquidity.

2. What Is Binance bStocks? Why Not Just Put US Stocks as BEP-20 Tokens?

According to Binance's official FAQ, bStocks are issued by BTech Holdings Limited. BTech is a special purpose vehicle registered in the Abu Dhabi Global Market (ADGM). The bStock is designed, through the relevant registration statements, securities prospectus, and product terms, to provide holders with economic exposure to specific listed stocks or ETFs. Binance bStocks FAQ

This means the BEP standard on-chain is merely the technical carrier. What truly defines the product is the following structure:

• Who bears the issuance obligation for the security certificate;
• Who buys and custodies the underlying stocks;
• What legal claims token holders have;
• Under what conditions minting, conversion, and redemption occur;
• How corporate actions, taxes, and market disruptions are handled;
• Which countries, regions, and users are eligible to participate.

Thus, bStocks are more accurately understood as "security certificates in token form." They are not a simple copy of a stock certificate onto a blockchain, nor are they a crypto token issued by Binance with the same name as a stock.

3. Does Buying 1 CRMB Equal Holding 1 Share of Salesforce? Does 1 HIMSB Equal 1 Share of Hims?

No—it does not equal direct shareholding.

Binance explicitly states that bStock holders are not direct shareholders of the underlying company and do not directly receive voting rights, shareholder communications, inspection rights, cash dividend rights, or other rights enjoyed by holders of the underlying securities. Binance holder rights statement

The difference between traditional stocks and bStocks can be understood as follows:

• Holding CRM or HIMS directly in a securities account means your assets are recorded within the traditional securities settlement and custody system;
• Holding CRMB or HIMSB means you hold a tokenized security issued by BTech that provides corresponding economic exposure under the product documentation;
• bStocks may be convertible into underlying stocks when conditions are met, but actual rights and operations remain subject to user eligibility, taxes, settlement, market conditions, and product terms.

Therefore, "the price aims to track one share of stock" and "legally owning one share of stock" are two different things. The former describes economic performance; the latter describes ownership and shareholder rights.

4. What Does "1:1 Backing" Mean? How Can You Verify That CRMB and HIMSB Are Backed by Actual Stocks?

Binance states that each bStock is intended to be backed by the corresponding underlying securities or other eligible assets through the custodial arrangements specified in the product documentation, with daily public and verifiable Proof of Collateral. Binance bStocks mechanism

Investors should not stop at the phrase "1:1." A more thorough verification includes at least:

1. Checking the on-chain effective supply of CRMB and HIMSB;
2. Reviewing the latest Proof of Collateral timestamp;
3. Confirming the quantity of underlying securities for each product;
4. Calculating the collateral coverage ratio (value or quantity of eligible collateral vs. effective token exposure);
5. Reading the securities prospectus, custody arrangements, and issuer rights;
6. Confirming whether securities lending, taxes, rounding, or operational limits apply;
7. Checking conversion and redemption rules under extreme market conditions.

"1:1 backing" also does not necessarily mean that one on-chain raw token always equals one share. Corporate actions such as cash dividends, stock splits, and reverse splits may adjust the effective balance via the Multiplier. The balance you see in the interface may be the Raw Balance multiplied by the Multiplier.

5. How Do CRMB and HIMSB Convert Between Stocks and Tokens?

Eligible users can convert direct stock holdings into corresponding bStocks, or convert bStocks back to underlying stocks per the product process. The basic flow is:

CRM or HIMS shares → Issuance & custody system → CRMB or HIMSB → Transfer on BNB Chain or trade on Binance → Convert back to underlying securities.

Binance's FAQ currently states that stock-to-token conversions can be processed 24/7 with zero conversion fees and that daily proof of collateral is published. However, "zero conversion fee" does not mean total cost is zero—trading spreads, network gas, taxes, withholding taxes, third-party fees, and market impact may still apply. Binance bStocks conversion details

Conversion is not unconditional. Market disruptions, corporate actions, eligibility checks, sanctions requirements, technical maintenance, and operational constraints can delay, suspend, or reject applications. For large holders, whether the conversion path operates smoothly under real stress is more important than the "1:1" claim on the marketing page.

6. Why Can bStocks Trade 24/7 While Salesforce and Hims Stocks Close?

CRM and HIMS trade on traditional U.S. markets with regular, pre-market, and after-hours sessions, and are closed on weekends and holidays. Once CRMB and HIMSB become on-chain tokens and enter Binance Spot, they can trade 24/7 like other supported digital assets.

This is a key utility of bStocks: crypto-native investors can manage stock exposure with USDT and transfer or trade even when U.S. markets are closed. But extended trading hours are not a pure advantage—they combine "continuous trading" with "intermittent underlying market trading," creating new pricing risks.

7. Do CRMB and HIMSB Prices Diverge from CRM and HIMS When U.S. Markets Are Closed?

Yes—at least temporarily.

Suppose major Salesforce AI news breaks over the weekend. CRM shares cannot price‑discover in the regular market, but CRMB can still be bought and sold. At that point, CRMB's price is driven by Binance order‑book supply/demand, market-maker depth, and traders' expectations of the next U.S. market open.

You can monitor the premium/discount with this formula:

Premium/Discount = (bStock Price ÷ Underlying Stock Reference Price − 1) × 100%.

For example, if CRM's latest tradable reference is $250 and CRMB trades at $260, the apparent premium is about 4%. But during a market holiday, that 4% may reflect new information expectations—or simply illiquid mispricing.

After the underlying market reopens, price convergence tends to occur via trading and conversion arbitrage. Buyers who paid a high premium may lose money even if their directional view on the company proves correct. So before placing an order, always check both CRMB vs. CRM and HIMSB vs. HIMS prices—not just the token's candlestick chart.

8. Salesforce Fundamentals: Why CRMB Isn't Just About the "AI Narrative"

CRMB's long-term direction depends first on whether Salesforce can consistently grow revenue, profits, and free cash flow.

For the FY2027 second quarter ended July 31, 2026, Salesforce reported:

• Revenue: $11.3 billion, up 11% YoY;
• Subscription and Support Revenue: $10.8 billion, up 12% YoY;
• cRPO: $33.5 billion, up 14% YoY;
• GAAP Operating Margin: 20.5%; Non-GAAP Operating Margin: 34.1%;
• Operating Cash Flow: $1.3 billion, up 71% YoY;
• Free Cash Flow: $1.1 billion, up 81% YoY.

The company also raised FY27 full-year revenue guidance to 46.1–46.4 billion, representing approximately 11–12% YoY growth. However, that guidance includes contributions from Informatica and the planned acquisitions of Contentful and Fin—so not all growth should be attributed to organic acceleration. Salesforce FY27 Q2 results

For CRMB investors, cRPO is more important than quarterly revenue alone, as it reflects contracted revenue expected to be recognized over the next 12 months. If cRPO consistently outpaces revenue growth, it usually signals strong future revenue momentum; if both slow simultaneously, AI hype alone cannot sustain the valuation.

9. Is Agentforce Truly Salesforce's Second Growth Engine?

Salesforce disclosed that in FY27 Q2, Agentforce and Data 360 ARR reached nearly $3.9 billion, up over 210% YoY; Agentforce ARR exceeded $1.5 billion, up over 240% YoY. The company also stated that Agentforce and Slack have delivered a cumulative 7 billion Agentic Work Units, with 3.2 billion in Q2 alone, up 97% QoQ. Salesforce Agentforce data

These numbers prove that AI products have generated quantifiable commercial activity. However, investors should note changes in reporting口径. Salesforce noted that starting FY27 Q2, Agentforce ARR includes certain AI products, Slackbot, and Headless 360. The high growth rate may be amplified by business expansion, scope changes, and a low base.

Key points to continually verify:

• Whether customers move from trials to scaled paid usage;
• Whether AI revenue increases average revenue per customer, rather than replacing seat-based revenue;
• Whether Data 360 and Informatica create a data moat;
• Whether inference and model costs compress gross margins;
• Whether Agentforce usage translates into stable ARR and cash flow;
• Whether AI growth lifts core businesses like Sales Cloud, Service Cloud, and Slack.

The bull case for CRMB is not "the market continues to talk about AI"—it's that Salesforce proves AI can re-accelerate a mature CRM business.

10. Salesforce Valuation: When Might CRMB Be Overvalued?

Salesforce is a large, mature software company; revenue growth alone is insufficient. CRMB investors should simultaneously monitor Revenue Growth, cRPO Growth, Operating Margin, Free Cash Flow, EPS, Forward P/E, EV/FCF, and Agentforce ARR.

A common risk is valuation expansion outpacing fundamentals. If CRM's share price rises mainly from multiple expansion while revenue, cRPO, and FCF fail to accelerate, even a slight miss on growth expectations can trigger a sharp pullback.

Also distinguish organic growth from M&A contributions. Informatica, Contentful, and Fin may increase revenue scale, but they bring integration, goodwill, cost, and execution risks. Higher revenue does not automatically mean higher per-share value.

11. Hims Fundamentals: Why HIMSB Is a Different Kind of Growth Stock

Hims & Hers Health is a direct-to-consumer digital health and wellness platform covering sexual health, dermatology, mental health, and weight loss, generating revenue through subscriptions, telehealth services, pharmaceuticals, and fulfillment.

In its Q2 2026 10-Q filed with the SEC:

• Q2 Revenue: $753.2 million, up 38% YoY;
• Subscribers at period end: ~2.891 million, up 19% YoY;
• Monthly Revenue per Average Subscriber: $92, compared to $76 in the prior-year period;
• U.S. revenue: $621.8 million, up 16% YoY;
• International revenue: $131.4 million, driven largely by acquisitions and geographic expansion.

These figures show Hims remains in a rapid growth phase, but the 38% total revenue growth is not entirely organic from existing U.S. operations. Acquisitions like Eucalyptus significantly boosted international revenue—so HIMSB analysis must separate organic growth from M&A contributions. Hims 2026 Q2 10-Q

12. Hims Revenue Up 38%—Why Are Profits and Gross Margins Deteriorating?

This is the most critical contradiction in the HIMSB investment thesis.

Hims reported Q2 gross profit of $480.8 million, with a gross margin of 64%, down from 76% in the prior-year period; GAAP Net Loss of $86.3 million, versus net income of $42.5 million a year ago. Adjusted EBITDA was $60.3 million, down from $82.2 million; Adjusted EBITDA Margin fell from 15% to 8%. Hims earnings and non-GAAP metrics

The company attributed the gross margin decline primarily to: shorter shipping cycles and higher fulfillment costs for weight-loss products, growth in international operations and newer products, non-recurring restructuring costs related to the 2026 U.S. weight-loss business adjustment, and recent acquisitions.

This means "revenue growth" and "growth quality" must be separated. Hims can rapidly expand revenue through more branded drugs, acquisitions, and frequent shipments, but if unit economics, fulfillment costs, and customer acquisition spend worsen, shareholder value may not increase proportionally.

Moreover, Adjusted EBITDA excludes legal matters, stock-based compensation, depreciation/amortization, transaction costs, restructuring charges, etc. It helps observe operating trends but does not replace GAAP net income and cash flow.

13. Hims' Biggest Opportunity—and Why Weight-Loss Is Both Catalyst and Risk

Global demand for GLP‑1 and weight-loss therapies gives Hims a new user funnel, higher average order value, and cross-selling opportunities. If the platform can expand branded drug coverage, increase Hers penetration, improve retention, and successfully integrate international acquisitions, revenue may sustain fast growth.

But the same business brings the hardest-to-forecast risks:

• Branded GLP‑1 supply and procurement terms may change;
• Compounded drug availability is affected by regulatory and shortage status;
• Advertising, prescription, and telehealth compliance could tighten;
• Mix shift toward branded drugs may depress gross margins;
• Shorter shipping cycles increase fulfillment costs;
• Competition may raise Customer Acquisition Cost;
• Rapid acquisitions and international expansion increase integration risk.

Hims itself noted in SEC filings that product availability and regulatory environment affect revenue. Therefore, HIMSB's high growth requires a higher risk discount—and cannot be assessed by subscriber numbers alone.

14. What Are the Fundamental Differences Between CRMB and HIMSB?

CRMB represents economic exposure to a mature, large-cap enterprise software company. Salesforce has massive subscription revenue, contract liabilities, free cash flow, and buyback capacity. Its main tension is whether the mature business can re-accelerate through AI, and whether the valuation already reflects Agentforce success.

HIMSB represents economic exposure to a high-growth digital health company. Hims has faster revenue and user growth, but also greater volatility in margins, regulatory risks, drug supply, customer acquisition, and acquisition integration.

Thus:

• CRMB is better analyzed with cRPO, Operating Margin, FCF, and AI ARR;
• HIMSB is better analyzed with Subscribers, ARPU, Gross Margin, CAC, weight-loss business, and regulatory events;
• Both share the same bStocks issuance, custody, redemption, contract, regional restrictions, and premium/discount risks.

Same product structure ≠ same company risk.

15. What Variables Drive CRMB and HIMSB Prices?

CRMB tracks CRM stock most directly. Long-term variables include Salesforce Revenue, cRPO, Agentforce ARR, margins, free cash flow, M&A integration, and large-cap software valuations.

HIMSB tracks HIMS stock most directly. Long-term variables include Revenue Growth, Subscribers, Monthly Revenue per Average Subscriber, Gross Margin, Adjusted EBITDA vs. GAAP profits, weight-loss business, customer retention, drug availability, and regulatory news.

Both are also affected by token market structure:

• Premium or discount of bStock relative to underlying stock;
• Order-book depth of CRMB/USDT and HIMSB/USDT;
• U.S. market open/close and major news timing;
• Smoothness of stock-token conversion;
• BNB Chain deposit/withdrawal and network status;
• Stablecoin liquidity and overall crypto risk appetite.

Long-term direction is driven by CRM and HIMS; the traded price is the result of "underlying stock value + token market premium/discount."

16. How Are Dividends Handled for CRMB and HIMSB? Will You Receive Cash?

Generally not as USDT or cash tokens directly into your wallet.

Binance's FAQ states that if the issuer receives cash dividends or similar distributions on underlying securities, it typically intends to reinvest the net amount (after applicable withholding taxes, fees, and other costs) into the same underlying securities, then adjust the effective balance of the corresponding bStock via the Multiplier. Binance bStocks dividend mechanism

Salesforce already pays quarterly cash dividends, so CRMB holders in particular need to understand that you may see a change in effective token balance—not a separate cash payment. Actual outcomes are also subject to record dates, ex-dividend dates, taxes, rounding, and processing times.

Whether Hims pays dividends or its future capital allocation policy should be based on company announcements. Even if the underlying company does not pay dividends, the Multiplier may still change due to other corporate actions like stock splits.

17. What Happens to CRMB and HIMSB If CRM or HIMS Splits?

Stock splits do not create economic value—they increase share count and proportionally reduce per-share price. bStocks handle these through the Multiplier.

For example, if the underlying stock undergoes a 2-for-1 split, the effective balance would theoretically double, and the per-unit price would halve, leaving total economic exposure unchanged (ignoring market fluctuations, fees, and rounding). Reverse splits work in the opposite direction.

Note that the smart contract's Raw Balance may remain unchanged; wallets, block explorers, and Binance interfaces that support the BEP-677 Scaled UI Amount will display the effective balance after applying the Multiplier. Wallets that do not properly integrate this standard may show different numbers. Binance Multiplier explanation

18. What New Risks Does 24/7 Trading Add That Traditional Stocks Don't Have?

18.1 Off-hours Premium

When U.S. markets are closed but bStocks continue trading, tokens may trade at high premiums due to expectations and limited liquidity.

18.2 Low-Liquidity Spread

During nights or weekends, participation is thinner; bid-ask spreads and large-order slippage can be significantly wider than for CRM or HIMS shares.

18.3 Reopening Gap

After the underlying market reopens, the new price may differ from the bStock's holiday-period expectations, and the spread reprices quickly.

18.4 Redemption Constraint

Corporate actions, market disruptions, or operational limits may suspend deposits, withdrawals, conversions, redemptions, or even spot trading. Binance's FAQ shows that certain functions may be suspended during dividend reinvestment; stock splits and reverse splits impose broader restrictions. Binance corporate action service arrangements

18.5 Information Asymmetry

Crypto traders may be unfamiliar with 8-Ks, 10-Qs, earnings calls, and U.S. corporate actions, making decisions based solely on token price movements.

19. CRMB Investment Strategy: Bull, Base, and Bear Scenarios

CRMB Bull Case

The optimistic scenario requires Salesforce organic revenue re‑acceleration, cRPO consistently ahead of revenue growth, strong Agentforce & Data 360 ARR, AI lifting ARPU, smooth integration of Informatica, etc., while Operating Margin and FCF remain healthy. If valuation hasn't fully priced in all growth, CRMB may outperform alongside CRM.

CRMB Base Case

The neutral scenario sees revenue growth around 10–12%, AI expanding, but the core CRM remains a mature software grower with some contribution from M&A. Returns then depend more on real earnings and cash flow than on multiple expansion.

CRMB Bear Case

The pessimistic scenario includes Agentforce commercialization below expectations, cRPO slowing, AI costs compressing margins, poor large-acquisition integration, multiple contraction for software stocks, or CRMB trading at a significant premium to CRM. Even if the product still has users, excessive valuation could lead to drawdowns.

20. HIMSB Investment Strategy: Bull, Base, and Bear Scenarios

HIMSB Bull Case

The optimistic scenario requires revenue growth to remain robust, Subscribers and ARPU rising together, weight-loss expanding, branded supply stable, international acquisitions well integrated, and Gross Margin and Adjusted EBITDA Margin gradually recovering.

HIMSB Base Case

The neutral scenario sees revenue still growing, but more incremental contribution comes from lower-margin products or acquisitions, keeping gross margins subdued, and the market assigns a lower multiple. The company gets larger, but the stock may not rise commensurately.

HIMSB Bear Case

The pessimistic scenario includes GLP‑1 or compounded drug regulatory changes, supply disruptions, further gross margin erosion, rising CAC, subscriber growth deceleration, increased legal expenses, poor acquisition integration, and HIMSB trading at a high premium to HIMS.

HIMSB volatility is typically higher than CRMB's because the underlying company is more dependent on growth expectations and regulatory environment.

21. Why Can't CRMB and HIMSB Be Evaluated Like BTC or ETH?

BTC's long-term logic includes scarcity, monetary network, institutional adoption, and macro liquidity. You can use BTC price prediction and market cycles to gauge overall crypto risk appetite, but BTC rising does not directly increase Salesforce or Hims revenue.

ETH can be analyzed via network usage, stablecoins, DeFi, staking, and blockspace. ETH price prediction and Ethereum trends can help understand on-chain financial conditions, but CRMB and HIMSB do not share Ethereum protocol fees.

CRMB's core remains Salesforce cash flow and valuation; HIMSB's core remains Hims growth and margins.

Tokenization changes the way you trade and hold—it does not change the fundamentals of the underlying stock.

22. Why Is BNB Relevant to CRMB and HIMSB but Cannot Predict Stock Direction?

CRMB and HIMSB circulate on BNB Smart Chain; on-chain transfers require BNB for gas. So BNB real-time price and BNB/USDT market data, network congestion, wallet support, and dApp activity affect usage costs and transfer experience.

But whether Salesforce enterprise clients buy Agentforce or Hims users subscribe to weight-loss services does not automatically improve because BNB rises. BNB is an infrastructure variable, not an underlying corporate earnings variable.

23. What Does BNB Price Prediction Mean for bStocks Users?

BNB price prediction can help users observe BNB Chain risk appetite, gas costs, and ecosystem liquidity. If BNB Chain experiences network issues, congestion, or rapid capital outflows, on-chain transfers and DeFi usage of bStocks may be affected.

The correct relationship is: CRM and HIMS determine the main asset direction; BNB Chain determines part of the on-chain environment. A bullish BNB view does not imply higher underlying value for CRMB or HIMSB.

24. HIBT Tokenized Equity Seven‑Layer Analysis Framework

Layer 1: Underlying

Confirm whether the underlying is CRM or HIMS—do not confuse with similarly named tokens or products from different issuers.

Layer 2: Company Fundamentals

Analyze revenue, profit, cash flow, competitive advantages, and valuation—not typical crypto tokenomics.

Layer 3: Issuer

Confirm the issuer is BTech Holdings Limited, and read its SPV structure, prospectus, and risk disclosures.

Layer 4: Collateral

Check the latest Proof of Collateral, effective token supply, and collateral coverage ratio.

Layer 5: Redemption

Confirm eligibility, timing, fees, minimum quantities, suspension conditions, and actual execution path.

Layer 6: Market

Compare bStock price, underlying stock reference price, premium/discount, volume, spreads, and market depth.

Layer 7: Tokenization Risk

Assess issuer, custodian, broker, smart contract, operational, regulatory, tax, regional restrictions, and wallet freeze risks.

A material issue in any of the seven layers can turn a correct directional view into a losing trade.

25. Top 10 Risks for CRMB and HIMSB

1. Underlying Stock Risk – If CRM or HIMS shares fall, bStocks generally cannot rise independently for long.
2. Valuation Risk – The market may have already priced in high expectations for Agentforce or weight-loss.
3. Issuer Risk – Investors bear BTech's issuance structure and performance risk.
4. Custody Risk – Underlying securities depend on custody, brokerage, and settlement infrastructure.
5. Liquidity Risk – CRMB/HIMSB order books may be much thinner than CRM/HIMS shares.
6. Premium/Discount Risk – 24/7 trading may cause token prices to diverge from the stock reference value.
7. Redemption Risk – Conversion and redemption are subject to eligibility, market, operations, taxes, and constraints.
8. Corporate Action Risk – Dividends, splits, M&A, or suspensions may pause services.
9. Regulatory Risk – bStocks are not available to all users globally; restricted persons (e.g., U.S. persons) are generally prohibited—check local product pages.
10. Smart Contract and Transfer Risk – Technical risks from contracts, wallets, cross-platform transfers; issuers may restrict addresses due to legal, sanctions, or rules, including contract blacklisting. Binance address restrictions

26. Which Types of Investors Are CRMB and HIMSB Suitable For?

CRMB is better suited for investors willing to research mature large-cap tech, enterprise software, free cash flow, margins, and AI commercialization. It is not low-risk, but the underlying company's operating data is relatively established.

HIMSB is better suited for investors who can tolerate higher volatility, understand digital health and pharmaceutical regulation, and are willing to continuously track Subscriber Growth, Gross Margin, CAC, and GLP‑1 developments. High revenue growth should not be automatically interpreted as high-quality earnings.

Crypto-native short-term traders must also understand U.S. trading sessions, earnings dates, and corporate actions—and calculate premium/discount and actual slippage before entering.

Those less suited include: traders who only look at crypto gainers' lists, those unwilling to read company financials, those unable to bear both stock and token risks, and those who mistake "backed by real assets" for "cannot lose money."

27. Pre‑Trade Checklist for CRMB or HIMSB

• Verify asset name, issuer, BNB Smart Chain, and full contract address;
• Confirm you are not confusing CRMB with CRMOn, or HIMSB with HIMSon or HIMSx;
• Check the latest tradable reference price for CRM or HIMS;
• Calculate the bStock's premium/discount relative to the underlying;
• Review the bid-ask spread and order depth for CRMB/USDT or HIMSB/USDT;
• Confirm whether U.S. markets are currently open, pre-market, after-hours, or closed;
• Check for earnings, 8-Ks, regulatory news, or corporate actions today;
• Review the latest Proof of Collateral and its timestamp;
• Read your region's eligibility and conversion restrictions;
• Size positions based on maximum tolerable loss, not target returns;
• Prefer limit orders to control execution price;
• Avoid mistaking short-term positions for long-term allocations ahead of earnings or regulatory events.

28. FAQ: Most Common Questions About CRMB and HIMSB

What is CRMB?

CRMB is a Salesforce bStock issued by BTech Holdings Limited, designed to provide economic exposure to Salesforce stock (CRM) and circulating on BNB Smart Chain.

What is HIMSB?

HIMSB is a Hims & Hers Health bStock corresponding to the economic exposure of underlying stock HIMS—not an official cryptocurrency issued by Hims.

Are CRMB and HIMSB real stocks?

They are tokenized security certificates, not direct stock holdings in a traditional securities account. Holders do not become direct shareholders of Salesforce or Hims.

Does buying CRMB equal holding Salesforce stock?

Not exactly. CRMB tracks CRM's economic performance, but the issuance structure, custody, rights, trading channels, tax treatment, and risks differ.

Does buying HIMSB equal holding Hims stock?

Not exactly. HIMSB provides economic exposure related to HIMS but does not directly confer traditional shareholder rights.

Are CRMB and HIMSB backed 1:1 by stocks?

The product structure intends to back them with corresponding underlying securities or eligible assets, and Proof of Collateral is disclosed. Actual coverage should be verified with the latest proof, supply figures, and legal documentation.

Can bStocks be converted into stocks?

The official FAQ provides a conversion path between stocks and tokens, but actual usage is subject to eligibility, market conditions, taxes, operations, and regional restrictions.

Do bStocks have voting rights?

bStocks themselves do not directly confer voting rights in the underlying company. Users who require traditional shareholder rights should first research the conditions for conversion into underlying securities.

Do bStocks pay dividends?

Cash dividends on underlying stocks are generally not paid directly as cash to bStock holders; the issuer plans to reinvest the net amount after taxes and reflect it via the Multiplier on the effective balance.

Why can bStocks trade 24 hours?

Because tokens can trade continuously on Binance Spot and supported on-chain environments, while underlying stocks are still subject to traditional market session hours.

Why might CRMB and CRM prices differ?

Order-book supply/demand, liquidity, U.S. market holidays, fees, market disruptions, and conversion efficiency can all cause short-term premiums or discounts.

Why might HIMSB and HIMS prices differ?

Similar reasons as CRMB. If Hims regulatory news breaks during U.S. market holidays, HIMSB may also pre‑price market expectations.

Which is riskier, CRMB or HIMSB?

From the underlying company's operational volatility, HIMSB typically carries higher growth-stock, margin, and healthcare regulatory risks. From the product structure, both share the same issuance, custody, liquidity, premium/discount, and tokenization risks.

29. Conclusion: Stocks Enter the Crypto Account, but Value Still Comes from Salesforce and Hims

The significance of CRMB and HIMSB is that they bring economic exposure to Salesforce and Hims into an environment where you can trade with USDT, transfer on BNB Smart Chain, and benefit from 24/7 price discovery. This lowers the operational barrier for some crypto users to manage stock exposure—but it does not eliminate traditional stock risks.

CRMB ultimately must answer: Can Salesforce transform Agentforce and Data 360 from high‑growth new businesses into overall enterprise software growth, profits, and free cash flow—and has the current CRM valuation already priced in AI expectations?

HIMSB ultimately must answer: Can Hims restore Gross Margin and improve GAAP profitability while rapidly growing Subscribers and Revenue, and manage GLP‑1, drug supply, regulatory, customer acquisition, and acquisition integration risks?

On top of that, bStock investors bear additional risks from the issuer, custody, conversion, smart contracts, liquidity, premium/discount, and regional regulations.

Therefore, a sound analytical framework is:

Underlying Fundamentals + bStock Structure + Market Premium/Discount + Investor Risk Tolerance.

Not:

"Binance listed it, so it must go up."